News Results
There are 642,834 News Results
Jul 26, 2017
NEW ORLEANS, July 27, 2017 /PRNewswire/ -- Tidewater Inc. (NYSE: TDW) ("Tidewater" or the "Company") announced today that the Company received approval to list its new common stock with the...
Jul 31, 2017
HOUSTON, Aug. 1, 2017 /PRNewswire/ -- Vanguard Natural Resources, LLC announces that it successfully completed its financial restructuring and emerged from Chapter 11 as a new corporation under the name...
Aug 2, 2017
CALGARY, Aug. 3, 2017 /CNW/ - Pure Technologies Ltd. ("Pure" or the "Company") (TSX: PUR) announces its financial performance for the quarter ended June 30, 2017. Second Quarter (Q2) and...
Aug 3, 2017
IRVING, Texas, Aug. 4, 2017 /PRNewswire/ -- Vistra Energy (NYSE: VST), the parent company for TXU Energy and Luminant, today reported a second quarter 2017 net loss of $26 million....
Aug 6, 2017
BROOKLYN, N.Y., Aug. 7, 2017 /PRNewswire-USNewswire/ -- The world's biggest student-run cyber security event will get even bigger this year: Cyber Security Awareness Week (CSAW), founded 14 years ago by...
Aug 6, 2017
MONROVIA, Calif., Aug. 7, 2017 /PRNewswire/ -- Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune disease, asthma and allergic diseases, and cancer,...
Aug 7, 2017
WATERLOO, Ontario, Aug. 8, 2017 /PRNewswire/ -- OpenText(TM) (NASDAQ: OTEX, TSX: OTEX), the global leader in Enterprise Information Management (EIM) , today announced that its wholly-owned subsidiary, Galileo Acquisition Sub...
Aug 8, 2017
WAYNE, Penn., Aug. 9, 2017 /PRNewswire/ -- Egalet Corporation (Nasdaq: EGLT) (Egalet), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and commercializing innovative treatments for pain and other...
Aug 8, 2017
SAN DIEGO, Aug. 9, 2017 /PRNewswire/ -- Trovagene, Inc. (NASDAQ: TROV), a precision medicine biotechnology company, today announced company highlights and financial results for the second quarter ended June 30,...
Aug 9, 2017
WALTHAM, Mass., Aug. 10, 2017 /PRNewswire/ -- Syndax Pharmaceuticals, Inc. ("Syndax," the "Company" or "we") (Nasdaq: SNDX), a clinical stage biopharmaceutical company developing entinostat and SNDX-6352 in multiple cancer indications,...
